EIRGEN PHARMA LIMITED

Eirgen Pharma Limited is a Waterford-based global contract development and manufacturing organisation (CDMO) that specialises in high-potency oral solid-dose (OSD) products for both human and companion-animal health. Drawing on more than 20 years of experience, the company delivers science-led, research-driven solutions that help innovators bring life-changing therapies to market quickly and safely.

The firm offers a fully integrated suite of services, from analytical method development and formulation work through clinical-trial manufacturing, tech-transfer, commercial-scale production and specialised packaging. Its expertise covers oncology, hormonal and cytotoxic therapies, as well as soft-gel and veterinary formulations, all supported by GMP-certified facilities that meet the stringent requirements of the FDA, EMA and HPRA. By providing end-to-end support, Eirgen enables partners to accelerate timelines, reduce operational complexity and focus on core innovation while benefiting from robust regulatory assistance and transparent project management.